Additional Proxy Soliciting Materials (definitive) (defa14a)
April 09 2020 - 8:06AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
SCHEDULE
14A
(Amendment
No. 1)
(RULE
14a-101)
SCHEDULE
14A INFORMATION
Proxy
Statement Pursuant to Section 14(A) of the
Securities
Exchange Act of 1934
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
|
☐
|
Preliminary Proxy Statement
|
|
☐
|
Confidential, for Use
of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☐
|
Definitive Proxy Statement
|
|
☒
|
Definitive Additional
Materials
|
|
☐
|
Soliciting Material
Pursuant to § 240.14a-12
|
Aytu
BioScience, Inc.
|
(Name
of Registrant as Specified In Its Charter)
|
|
(Name
of Person(s) Filing Proxy Statement if other Than the Registrant)
|
|
Payment
of Filing Fee (Check the appropriate box):
|
☐
|
Fee computed on table
below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction
applies:
|
|
|
|
|
(2)
|
Aggregate number of securities to which transaction
applies:
|
|
|
|
|
(3)
|
Per unit price
or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
(5)
|
Total fee paid:
|
|
|
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
☐
|
Check box if any part of the fee is offset as
provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify
the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
(3)
|
Filing Party:
|
|
|
|
|
(4)
|
Date Filed:
|
|
|
|
AYTU
BIOSCIENCE, INC.
373
Inverness Parkway, Suite 206
Englewood,
Colorado 80112
NOTICE
OF ANNUAL MEETING OF STOCKHOLDERS
TO
BE HELD APRIL 23, 2020
To
the Stockholders of Aytu BioScience, Inc.:
On
April 9, 2020, Aytu BioScience, Inc. (the “Company”) a specialty pharmaceutical company focused on
commercializing novel products that address significant patient needs announced that, due to Colorado’s “shelter
in place” order related to the Coronavirus Disease (“COVID-19”) crisis, the Company has rescheduled the
upcoming annual meeting of the stockholders; originally scheduled for March 31, 2020; to April 23, 2020 at 11:00 AM, Mountain
Standard Time. Further instructions on how to attend, participate in and vote at the Virtual Annual Meeting, including how to
demonstrate stockholder ownership of the Company’s shares as of the record date, are available at:
www.virtualshareholdermeeting.com/AYTU2020
AYTU BioPharma (NASDAQ:AYTU)
Historical Stock Chart
From Aug 2024 to Sep 2024
AYTU BioPharma (NASDAQ:AYTU)
Historical Stock Chart
From Sep 2023 to Sep 2024